A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,273 shares of AVXL stock, worth $226,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,273
Previous 16,273 24.58%
Holding current value
$226,652
Previous $69,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$4.11 - $7.04 $16,440 - $28,160
4,000 Added 24.58%
20,273 $115,000
Q2 2024

Jul 26, 2024

SELL
$3.39 - $5.02 $339 - $501
-100 Reduced 0.61%
16,273 $69,000
Q1 2024

Apr 24, 2024

BUY
$4.55 - $6.75 $2,265 - $3,361
498 Added 3.14%
16,373 $83,000
Q4 2023

Feb 09, 2024

SELL
$5.04 - $9.95 $2,016 - $3,979
-400 Reduced 2.46%
15,875 $148,000
Q3 2023

Oct 24, 2023

BUY
$6.55 - $9.37 $106,601 - $152,496
16,275 New
16,275 $107,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $871M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.